Kane Biotech Inc. (TSXV:KNE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0350
0.00 (0.00%)
Apr 29, 2026, 9:47 AM EST

Kane Biotech Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.90.360.751.11.15
Cash & Short-Term Investments
0.90.360.751.11.15
Cash Growth
151.30%-52.11%-32.19%-4.18%14.40%
Accounts Receivable
0.040.090.10.580.6
Other Receivables
---0.480.48
Total Trade Receivables
0.040.090.11.061.07
Inventory
0.50.380.250.760.52
Other Current Assets
0.250.212.620.170.14
Total Current Assets
1.691.033.723.12.88
Net Property, Plant & Equipment
0.480.931.071.251.44
Other Intangible Assets
0.570.540.730.830.83
Other Long-Term Assets
--0.160.440.99
Total Assets
2.732.495.685.626.13
Accounts Payable
1.081.831.611.852.06
Short-Term Debt
1.250.816.974.172.38
Current Portion of Leases
0.080.120.110.10.13
Unearned Revenue
--0.750.210.14
Other Current Liabilities
0.10.31.460.010.01
Total Current Liabilities
2.52.4110.896.344.72
Long-Term Debt
0.622.671.31.61.12
Long-Term Leases
0.360.760.870.981.09
Other Long-Term Liabilities
--1.020.840.78
Total Long-Term Liabilities
0.981.713.23.422.98
Total Liabilities
3.484.1214.099.767.7
Common Stock
27.9724.423.6923.1322.16
Additional Paid-in Capital
8.428.387.897.447.17
Retained Earnings
-37.14-34.42-42.13-37.1-33.21
Total Common Shareholders' Equity
-0.75-1.63-10.56-6.52-3.89
Minority Interest
--2.152.382.32
Shareholders' Equity
-0.75-1.63-8.41-4.14-1.57
Total Liabilities & Equity
2.732.495.685.626.13
Total Debt
2.34.359.256.864.71
Net Cash (Debt)
-1.4-3.99-8.5-5.75-3.56
Net Cash Per Share
-0.01-0.03-0.07-0.05-0.03
Book Value
-0.75-1.63-10.56-6.52-3.89
Book Value Per Share
-0.00-0.01-0.08-0.05-0.03
Tangible Book Value
-1.31-2.17-11.29-7.35-4.71
Tangible Book Value Per Share
-0.01-0.01-0.09-0.06-0.04
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.